A2f Associates Limited

A2f Associates Limited is an SME in Newmarket, United Kingdom that has taken part in 5 EU-funded projects since 2015, receiving €1.6M in EU funding.

EU funding received€1.6M
EU projects5
As coordinator0
Running now0
First EU project2015
Latest project2019
CountryUnited Kingdom
EU registration (PIC)949884917
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are A2f Associates Limited's own share of each project, not the project's full budget.

  • Horizon 2020€1.6M · 5 projects

Projects

5 EU-funded projects, newest first. Each links to the official record.

  • CardioReGenixPartner

    CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €718ktheir share
  • ReGenHeartPartner

    Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €302ktheir share
  • T2DSystemsPartner

    Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €186ktheir share
  • BOOSTB4Partner

    Boost Brittle Bones Before Birth

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €259ktheir share
  • CARBALIVEPartner

    Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €138ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotics
  • cardiology
  • diabetes
  • fetal medicine
  • gene therapy
  • hepatology
  • immunology
  • infectious diseases
  • muscular dystrophies
  • nuclear medicine
  • obesity
  • personalized medicine
  • pharmaceutical drugs
  • productivity

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime